-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Diflucortolone valerate is a synthetic steroid drug that is used to treat a variety of inflammatory and immunological disorders.
It is a derivative of cortisol, a hormone that is produced by the adrenal gland, and has anti-inflammatory, immunosuppressive, and anti-inammatory properties.
The drug is used to treat conditions such as rheumatoid arthritis, dermatomyositis, and lupus erythematosus.
There are several synthetic routes that can be used to synthesize diflucortolone valerate.
One of the most common methods is the "Schweitzer route," which involves the synthesis of the compound via a series of chemical reactions.
This route involves the synthesis of the precursor compound, 11-dehydrocorticosterone, followed by a series of chemical transformations to produce diflucortolone valerate.
Another synthetic route to diflucortolone valerate is the "Widmaier-Trautwein route," which involves the reaction of 11-dehydrocorticosterone with acetone in the presence of an acid catalyst.
This route produces diflucortolone valerate in high yield and is considered to be more efficient than the Schweitzer route.
The synthesis of diflucortolone valerate via the Schweitzer route involves several steps, including the synthesis of 11-dehydrocorticosterone, the oxidation of 11-dehydrocorticosterone to 11-dehydroxycorticosterone, and the reduction of 11-dehydroxycorticosterone to diflucortolone valerate.
The oxidation step is typically carried out using potassium permanganate, while the reduction step is typically carried out using lithium aluminum hydride (LiAlH4).
The synthesis of diflucortolone valerate via the Widmaier-Trautwein route involves the reaction of 11-dehydrocorticosterone with acetone in the presence of an acid catalyst, such as hydrochloric acid or sulfuric acid.
This route is considered to be more efficient than the Schweitzer route as it involves fewer steps and produces dimethyl acetal of 11-dehydrocorticosterone, which can be easily converted into diflucortolone valerate.
The synthesis of diflucortolone valerate is a complex process that involves several steps and requires the use of specialized equipment and reagents.
The drug is typically synthesized in a laboratory setting by trained chemists and synthetic organic chemists.
The final product is then purified and processed for use as a pharmaceutical drug.
In conclusion, diflucortolone valerate is a synthetic steroid drug that is used to treat a variety of inflammatory and immunological disorders.
There are several synthetic routes that can be used to synthesize the drug, including the Schweitzer route and the Widmaier-Trautwein route.
The synthesis of the drug involves several steps and requires the use of specialized equipment and reagents.
The final product is then purified and processed for use as a pharmaceutical drug.